Anbio - Wutah pendapatan triwulanan NNNN

Simbol lan logo merek anbio.com (NNNN)

Quarterly revenue growth rates demonstrate the development dynamics of Anbio Biotechnology, where 87.20 serves as the base parameter value. Anbio Biotechnology complies with environmental standards during reagent disposal. Compact POCT systems, which enable rapid patient diagnosis, create a competitive advantage. The sale of laboratory equipment ensures revenue stability, although expansion into new markets remains a key factor for scaling the business.

NNNN Tingkat wutah pendapatan sajrone kuartal Anbio Corp (20.02.2025 - 20.11.2026)

Anbio - rincian analitis lan metrik utama (NNNN)

- rega saham lan target rega konsensus:
Analisis fundamental perusahaan:NNNN - Anbio Biotechnology Ltd
Produk sing diprodhuksi anbio.com

Investors must identify objective fundamental benchmarks within Anbio Biotechnology (NNNN) financial statements to accurately determine entry points. This indicator calculates quarterly revenue dynamics, allowing the quarterly sales growth chart to reveal market overheating and prevent purchasing the asset at its peak, which is particularly valuable for a stable, non-cyclical business in the medical diagnostics sector.

Pesaing utama

A - Wutah pendapatan kuartal marang kuartal|Tingkat wutah dodolan sajrone kuartal Quest Diagnostics Incorporated DGX|ILMN (illumina.com) - Wutah dodolan triwulanan|Wutah dodolan triwulanan Cologuard|RVTY (Revvity Corp) - Wutah pendapatan triwulanan|Wutah pendapatan triwulanan Bio-Rad Laboratories Inc|Wutah dodolan triwulanan SHC (Sotera Health Company)|Wutah pendapatan kuartal marang kuartal QDEL (quidel.com)|Wutah pendapatan triwulanan OPK (opko.com)|Tambahing pendapatan triwulanan CDNA|MRVI: Wutah dodolan triwulanan|Tambahing pendapatan triwulanan FLGT (Fulgent Corp)|LAB: Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal cytekbio.com (CTKB)|OSUR (OraSure Corp) - Wutah pendapatan triwulanan|Exagen (XGN) - Tingkat wutah dodolan sajrone kuartal|Wutah pendapatan kuartal marang kuartal MDxHealth, Inc. (MDXH)|Lucid Diagnostics, Inc - Wutah dodolan kuartal marang kuartal|Wutah pendapatan kuartal marang kuartal Prenetics PRE|Insight Molecular (IMDX) - Tingkat wutah pendapatan sajrone kuartal|Trinity Biotech Corp - Wutah pendapatan triwulanan|Tingkat wutah dodolan sajrone kuartal ProPhase PRPH|AIMD: Wutah pendapatan triwulanan|CODX - Tingkat wutah dodolan sajrone kuartal|Wutah pendapatan kuartal marang kuartal Heart Test Laboratories, Inc.|Wutah pendapatan kuartal marang kuartal BMRA|Wutah pendapatan triwulanan CDIO|Onconetix - Wutah dodolan kuartal marang kuartal|Wutah pendapatan kuartal marang kuartal viraxbiolabs.com VRAX|Tingkat wutah dodolan sajrone kuartal Bluejay (BJDX)|AWH: Wutah dodolan triwulanan|Tingkat wutah dodolan sajrone kuartal Accelerate Diagnostics, Inc. AXDX|Centogene (CNTG) - Wutah pendapatan kuartal marang kuartal|Dinamika pendapatan kuartal marang kuartal ENZ (Enzo)|Wutah dodolan kuartal marang kuartal Fresh2 (FRES)|Genetic Technologies (GENE) - Tingkat wutah dodolan sajrone kuartal|Wutah pendapatan triwulanan ME|Wutah pendapatan kuartal marang kuartal PMD (Psychemedics Corporation)